Sun Pharma Board Approves Fundraising of Up to ₹10,000 Crore via NCDs
Sun Pharmaceutical Industries said its board approved a proposal to raise up to ₹10,000 crore through non-convertible debentures at an October 12 meeting.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.